tiprankstipranks
Bio-Rad Laboratories (BIO)
NYSE:BIO
US Market

Bio-Rad Laboratories (BIO) Income Statement

Compare
873 Followers

Bio-Rad Laboratories Income Statement

Last quarter (Q4 2024), Bio-Rad Laboratories's total revenue was $667.50M, a decrease of -2.01% from the same quarter last year. In Q4, Bio-Rad Laboratories's net income was $-715.80M. See Bio-Rad Laboratories’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 2.57B$ 2.67B$ 2.80B$ 2.92B$ 2.55B
Gross Profit
$ 1.38B$ 1.43B$ 1.57B$ 1.64B$ 1.44B
Operating Expenses
$ 1.11B$ 1.05B$ 1.08B$ 1.15B$ 1.03B
Depreciation and Amortization
$ 151.60M$ 145.90M$ 177.20M$ 176.90M$ 175.20M
EBITDA
$ -2.14B$ -608.26M$ -4.49B$ 5.63B$ 5.10B
Operating Income
$ 269.00M$ 337.80M$ 482.62M$ 489.43M$ 410.96M
Other Income/Expenses
$ -2.61B$ -1.19B$ -5.19B$ 4.95B$ 4.49B
Pretax Income
$ -2.34B$ -850.10M$ -4.70B$ 5.44B$ 4.91B
Net Income
$ -1.84B$ -637.32M$ -3.63B$ 4.25B$ 3.81B
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -65.36$ -21.82$ -121.79$ 142.61$ 127.86
Diluted EPS
$ -65.36$ -21.82$ -121.79$ 140.83$ 126.20
Weighted Average Shares Outstanding
28.21M 29.21M 29.79M 29.83M 29.77M
Weighted Average Shares Outstanding (Diluted)
28.21M 29.21M 29.79M 30.21M 30.16M
Currency in USD

Bio-Rad Laboratories Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis